Alexandria Real Estate Equities Inc
ARE
View Detailed Chart
55.900USD
+0.770+1.40%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
9.53BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.40%
5 Days
+2.31%
1 Month
+6.72%
6 Months
-24.31%
Year to Date
+14.22%
1 Year
-42.14%
View Detailed Chart
TradingKey Stock Score of Alexandria Real Estate Equities Inc
Currency: USD Updated: 2026-02-06Key Insights
Alexandria Real Estate Equities Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 83 out of 191 in the Residential & Commercial REITs industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 65.07.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Alexandria Real Estate Equities Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
2°C
Very Low
Very High
Positive
Alexandria Real Estate Equities Inc Highlights
StrengthsRisks
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 293.00%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 293.00%.
Undervalued
The company’s latest PE is -6.62, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 169.52M shares, increasing 0.02% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 5.50K shares of this stock.
Analyst Rating
Based on
18
analysts
Hold
Current Rating
65.067
Target Price
+18.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Alexandria Real Estate Equities Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Alexandria Real Estate Equities Inc Info
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Ticker SymbolARE
CompanyAlexandria Real Estate Equities Inc
CEOMoglia (Peter M)
Websitehttps://www.are.com/
Related Instruments
+1.48%
+2.54%
+0.60%
+5.02%
-0.12%
+1.19%
+4.11%
-0.21%
+2.10%
+3.41%
+3.22%
+0.03%
+1.01%
+7.68%
+2.36%
+3.43%
+1.57%
+0.13%
-0.26%
+2.61%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68917.460
-1052.670 (-1.50%)
282.580
+22.390 (+8.61%)
2036.520
-15.210 (-0.74%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
